PlumX Metrics
Embed PlumX Metrics

Oncology, Volume 56, Number 09, September 2011

2011
  • 0
    Citations
  • 59
    Usage
  • 0
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Newsletter Description

Novel Agents for Castrate-Resistant Prostate Cancer Include Potent Androgen Blockers and Immunotherapies: Despite progress in screening and therapy, prostate cancer continues to be a leading cause of cancer death among men worldwide New Targeted Therapy Offers Hope in Relapsed Hodgkin and Anaplastic large-Cell Lymphoma: The U.S. Food and Drug Administration (FDA) has approved the first new drug for Hodgkin Lymphoma since 1977 HOUSE CALL: Colorectal Cancer Screening: Risk factors determine who should be screened and how often IN BRIEF: Everolimus may Overcome Trastuzumab Resistance in HER2-Positive Breast Cancer Patients

Bibliographic Details

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know